Features & Compatibility
Tirzepatide is a modified peptide that acts as a dual agonist of the GIP and GLP-1 receptors. Its dual-receptor profile makes it a valuable compound for laboratory research involving metabolic signaling, glucose-dependent pathways, glucagon regulation, energy balance, and related biological mechanisms.
Tirzepatide provides researchers with a useful reference for studying the interaction between GIP and GLP-1 pathways in controlled laboratory environments. FDA reference
Variants:
5mg10vials | 10mg10vials | 15mg10vials | 20mg10vials | 30mg10vials | 40mg10vials | 50mg10vials | 60mg10vials | 100mg10vials | 120mg10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
BPC+TB500
This research blend combines BPC-157 and TB-500, two peptides investigated in laboratory models involving cellular repair and tissue-response mechanisms. BPC-157
Cardiogen
Cardiogen is a short synthetic tetrapeptide composed of Alanine, Glutamic Acid, Aspartic Acid and Arginine (Ala-Glu-Asp-Arg), abbreviated as AEDR. It
Eloralintide
Eloralintide, formerly known as LY3841136, is an investigational, long-acting and selective amylin receptor agonist. It is designed to mimic amylin,
Ipamorelin
Ipamorelin is a synthetic peptide and selective growth hormone secretagogue receptor (GHS-R) agonist. It is studied for its ability to
Semaglutide
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely
TB500(Thymosin B4 Acetate)
TB-500 is a synthetic research peptide related to Thymosin Beta-4, a naturally occurring actin-binding peptide involved in cellular organization and

Reviews
There are no reviews yet.